The survival time after liver metastasis of pancreatic neuroendocrine tumor is related to the metastatic lesion and the patient’s physical quality, so it is impossible to make accurate judgment, and it is recommended to improve the prognosis by active treatment under the guidance of doctors.
If in the early stage of liver metastasis, the metastatic foci and primary foci are more limited, and the patient’s body can tolerate surgery, surgery can be taken to completely remove the foci to treat the disease.
If the liver metastatic lesions are multiple and large, or if the patient cannot tolerate surgery, chemotherapy and targeted therapy are needed to shrink the tumor lesions, improve the prognosis of the disease and prolong the survival time.
Therefore, after discovering the liver metastasis of pancreatic neuroendocrine tumor, it is recommended to actively cooperate with doctors to receive treatment to promote the improvement of disease prognosis and prolong the patient’s life.